Start-up developing a novel class of therapeutic RNAs
Transine Therapeutics Announces Final Closing of its Seed Round at £13.7m
07-Jun-2022 -
Transine Therapeutics, a biotechnology start-up company developing a novel class of therapeutic RNAs based on its pioneering SINEUP® platform technology, announces that it has successfully raised £4.6 million in additional seed funding. The financing was led by new investor Epidarex Capital with ...
funding
RNA